[1] CERQUERIA B B S, LASHAM A, SHELLING A N, et al. Nanoparticle therapeutics:technologies and methods for overcoming cancer[J]. Eur J Pharm Biopharm,2015,97(2015):140-151. [2] PEROVIC I, DAVIDYANTS A, EVANS J S. Aragonite-associated mollusk shell protein aggregates to form mesoscale "smart" hydrogels[J]. ACS Omega,2016,1(5):886-893. [3] BHARATHAM B H, ABU BAKAR M Z, PERIMAL E K, et al. Development and characterization of novel porous 3d alginate-cockle shell powder nanobiocomposite bone scaffold[J]. Biomed Res Int,2014,2014:146723. [4] FU W L, NOHD M H, YUSOF L M, et al. In vitro evaluation of a novel pH sensitive drug delivery system based cockle shell-derived aragonite nanoparticles against osteosarcoma[J]. J Exp Nanosci,2017,12(1):166-187. [5] HORIE M, LWAHASHL H. The impact of the physiochemical properties of manufactured nanoparticles on in vitro and in vivo evaluation of particle toxicity[J]. J Phys Chem Biophys,2014,4(2):139. [6] GOWADA S, DESAI P B, HULL V V, et al. A review on laboratory liver function tests[J]. Pan Afr Med J,2009,3:1-11. [7] SWAMY A V, GULLIAYA S, THIPPESWAMY A, et al. Cardioprotective effect of curcumin against doxorubicin-induced myocardial toxicity in albino rats[J]. Indian J Pharmacol,2012,44(1):73-77. [8] LUETKE A, MEYERS P A, LEWIS I, et al. Osteosarcoma treatment - where do we stand? a state of the art review[J]. Cancer Treat Rev,2014,40(4):523-532. [9] THEEK B, RIZZO L Y, EHLING J,et al. The theranostic path to personalized nanomedicine[J]. Clin Transl Imaging,2014,2:67-76. [10] LEU A J, BERK D A, LYMBOUSSAKI A, et al. Absence of functional lymphatics within a murine sarcoma:a molecular and functional evaluation[J]. Cancer Res,2000,60(16):4324-4327. [11] BARUA S, MITRAGOTRI S. Challenges associated with penetration of nanoparticles across cell and tissue barriers:a review of current status and future prospects[J]. Nano Today,2014,9(2):223-243. [12] XU J Y, SHI H B, RUTH M, et al. Acute toxicity of intravenously administered titanium dioxide nanoparticles in mice[J]. PLoS One,2013,8(8):e70618. [13] ARIKA W M, NYAMAI D W, MUSILA M N, et al. Hematological markers of in vivo toxicity[J]. J Hematol Thrombosis Dis,2016,4(2):236. [14] CAMPBELL T W. Exotic animal hematology and cytology[M]. Wiley Blankwell:John Wiley Sons,2015,383-391. [15] MICHAEL B, YANO B, SELLERS R S, et al. Evaluation of organ weights for rodent and non-rodent toxicity studies:a review of regulatory guidelines and a survey of current practices[J]. Toxicol Pathol,2007,35(5):742-750. [16] BLUM J L, ROSENBLUM L K, GRUNIG G, et al. Short-term inhalation of cadmium oxide nanoparticles alters pulmonary dynamics associated with lung injury, inflammation, and repair in a mouse model[J]. Inhal Toxicol,2014,26(1):48-58. [17] AMAN J, VAN DERHEIJDEN M,VAN LINGEN A, et al. Plasma protein levels are markers of pulmonary vascular permeability and degree of lung injury in critically ill patients with or at risk for acute lung injury/acute respiratory distress syndrome[J]. Crit Care Med,2011,39(1):89-97. [18] YU Y, LI Y, WANG W, et al. Acute toxicity of amorphous silica nanoparticles in intravenously exposed ICR mice[J]. PLoS One,2013,8(4):e61346. [19] YU T, GREISH K, MCGILL L D, et al. Influence of geometry, porosity and surface characteristics of silica nanoparticles on acute toxicity:their vasculature effect and tolerance threshold[J]. ACS Nano,2012,6(3):2289-2301. [20] PETERSEN H J, SMITH A M. The role of the innate immune system in granulomatous disorders[J]. Front Immunol,2013,4:120. [21] PU F, CHEN N, XUE S. Calcium intake, calcium homeostasis and health[J]. Food Sci Hum Wellness,2016,5:8-16. |